Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size


 
Table of Contents   
LETTER TO THE EDITOR
Year : 2020  |  Volume : 15  |  Issue : 2  |  Page : 102
Hemoptysis in COVID-19: Observation


1 KMT Primary Care Center, Bangkok, Thailand
2 Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India; Department of Tropical Medicine, Hainan Medical University, Haikou, China

Date of Submission21-Feb-2020
Date of Decision22-Feb-2020
Date of Acceptance22-Feb-2020
Date of Web Publication03-Apr-2020

Correspondence Address:
Sora Yasri
KMT Primary Care Center, Bangkok
Thailand
Login to access the Email id


DOI: 10.4103/atm.ATM_67_20

Rights and Permissions



How to cite this article:
Yasri S, Wiwanitkit V. Hemoptysis in COVID-19: Observation. Ann Thorac Med 2020;15:102

How to cite this URL:
Yasri S, Wiwanitkit V. Hemoptysis in COVID-19: Observation. Ann Thorac Med [serial online] 2020 [cited 2020 May 26];15:102. Available from: http://www.thoracicmedicine.org/text.asp?2020/15/2/102/281872




Sir,

COVID-19 is a new emerging infection. This disease was first discovered in a province of China.[1] The disease already spread to several countries, including Thailand, Singapore, and Korea.[2] As a new disease, the clinical presentation of this new infection is an interesting topic. An important clinical presentation in respiratory disease is hemoptysis. In previous new emerging coronavirus infections such as MRES and SARS, hemoptysis has never been mentioned. Here, the authors would like to discuss on observation on hemoptysis in COVI-19.

From data on 35 patients in our setting (February 20, 2020), Thailand, no patient presents hemoptysis. From summarizing of available published data on 140 patients with COVID-19 from China,[3],[4] two patients present hemoptysis, giving rate equal to 1.43% (95% confidence interval = 0.36%–5.66%). Here, it can show that hemoptysis might be a possible clinical presentation of COVID-19 although it is not common. A practitioner should recognize this clinical possibility.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study Case Rep 2020;10:8-9.  Back to cited text no. 1
    
2.
Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Public Health Int 2020;10:1-2.  Back to cited text no. 2
    
3.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74.  Back to cited text no. 3
    
4.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507-13.  Back to cited text no. 4
    




 

Top
Print this article  Email this article
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (277 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed638    
    Printed6    
    Emailed0    
    PDF Downloaded125    
    Comments [Add]    

Recommend this journal